Our innovations feature Apostle MagTouch Nucleic Acids Isolation Automation System, Apostle MiniMax cfDNA technologies (see Science), and others.
Our response to help our community fight COVID-19 together: high quality, low cost, fast, safe, Apostle COVID-19 Viral RNA Isolation Automation System. Over 8 million samples processed. Clinically validated. Included in a US FDA EUA authorized Molecular Diagnostic Test for SARS-CoV-2.
Serviced over 8 million people from all over the country since 2017
Introducing MagTouch 2000
The MagTouch 2000 instrument is an automatic extraction and purification system for nucleic acids from various types of biological samples collected in multiple transport media. It can absorb, transfer and release magnetic beads by a magnetic rod and magnetic rod sleeve to separate magnetic beads and samples. The operation is automatic, fast and simple. Compared with our earlier model 1000, the new model 2000 is easier to use, more robust, and has a smaller foot print.
Apostle COVID-19 RNA Extraction System is a fast and reliable solution for SARS-CoV-2 viral RNA extraction. We look forward to continuing the collaboration with Apostle and providing high quality COVID-19 tests for our community.
- Harry Gao, MD, PhD, DABMG, FACMG, Lab Director and Chief Scientific Officer, Fulgent Genetics
Apostle RNA Extraction Method is Included in a US FDA EUA Authorized SARS-CoV-2 Molecular Diagnostic Test: Fulgent COVID-19 by RT-PCT Test
Apostle Inc is pleased to announce that the company’s Apostle RNA Extraction Method is included in the recent US FDA EUA authorization of a SARS-CoV-2 Molecular Diagnostic Test: Fulgent COVID-19 by RT-PCT Test, as reagent and system used with the FDA EUA authorized test. ....read more
Apostle Inc is a biotechnology company in San Jose, CA, a provider of innovative technologies and services for public health and life sciences. Apostle aims to develop innovative technologies in the space of liquid biopsy - the sampling and analysis of non-solid biological tissue, primarily blood, often utilizing circulating free DNA (cfDNA) as a biomarker.
In 2020, the company responded to the COVID-19 pandemic to help our community fight together with a high quality, low cost, fast, automated, Apostle COVID-19 Viral RNA Isolation System.